Latest Articles
Why Jemperli and Zejula will be key assets in GSK’s India oncology portfolio? - Business Today
Why Jemperli and Zejula will be key assets in GSK’s India oncology portfolio? Business Today
Published: Aug. 26, 2025, 12:29 p.m.
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers - BW Healthcare
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers BW Healthcare
Published: Aug. 26, 2025, 8:55 a.m.
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers - BW Healthcare World
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers BW Healthcare World
Published: Aug. 26, 2025, 8:55 a.m.
GSK expands cancer treatment options in India with launch of immunotherapy and PARP inhibitor - connectedtoindia.com
GSK expands cancer treatment options in India with launch of immunotherapy and PARP inhibitor connectedtoindia.com
Published: Aug. 26, 2025, 4:39 a.m.
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers - India Education Diary
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers India Education Diary
Published: Aug. 25, 2025, 3:28 p.m.
GSK forays into oncology in India bringing precision therapies for gynaecological cancers - BioSpectrum India
GSK forays into oncology in India bringing precision therapies for gynaecological cancers BioSpectrum India
Published: Aug. 25, 2025, 2:19 p.m.
GSK Launches Jemperli for Advanced Endometrial Cancer and Zejula for Ovarian Cancer in India - geneonline.com
GSK Launches Jemperli for Advanced Endometrial Cancer and Zejula for Ovarian Cancer in India geneonline.com
Published: Aug. 25, 2025, 12:03 p.m.
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers - APN News
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers APN News
Published: Aug. 25, 2025, 11:04 a.m.
GSK introduces Jemperli and Zejula in India to expand oncology portfolio - Express Pharma
GSK introduces Jemperli and Zejula in India to expand oncology portfolio Express Pharma
Published: Aug. 25, 2025, 11 a.m.
GSK forays into oncology in India with Jemperli and Zejula - Indian Pharma Post
GSK forays into oncology in India with Jemperli and Zejula Indian Pharma Post
Published: Aug. 25, 2025, 10:23 a.m.
Link copied to clipboard!